Neuroimmunology Program - IDIBAPS

Electroretinograma and Aubagio®

Which are the aims?

It is an observational study in patients with multiple sclerosis who start treatment with Aubagio®. Electroretinography informs about quality and speed of signal conduction between neurons in the retina. Prior to retinal neuronal loss, there are functional changes (impaired signal quality). In this study, we aim to evaluate retinal of signal conduction before and after starting treatment with Aubagio®. These changes will be valuable in order to understand the potential of this technology to predict the patient´s response to the therapy.

Which are the results so far?

We have not finished the recruitment of this project yet. First patients entering the study will have the second evaluation by second quarter of 2017.

What are we looking for and how could you help us?

If you are a patient, we would like to encourage you to participate in this study that will not interfere with standard healthcare in your hospital. We will provide you with all the results so they will be available for your treating physician´s evaluation at your reference hospital.